68Ga-DOTATATE Neuroblastoma Imaging Pilot

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

December 15, 2026

Study Completion Date

September 30, 2027

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

Radiopharmaceutical 68Ga-DOTATATE

Injection of 68Ga-DOTATATE followed by PET/CT acquisition

Trial Locations (3)

H4A 3J1

WITHDRAWN

McGill University Health Center - Children's hospital, Montreal

J1H 5N4

RECRUITING

CHU Ste-Justine, Montreal

RECRUITING

CIUSSS de l'Estrie-CHUS Hospital, Sherbrooke

All Listed Sponsors
lead

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

OTHER